Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett's esophagus.

T Kollar1, J Majek, P Slezak

  • 1National Cancer Institute, Bratislava, Slovakia. kollar@nou.sk

Bratislavske Lekarske Listy
|July 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recombination of HCO+ ions with electrons in the temperature range of 80-200 K.

The Journal of chemical physics·2025
Same author

In-vitro antiplatelet effect of melatonin in healthy individuals and patients with type 2 diabetes mellitus.

Journal of endocrinological investigation·2023
Same author

Ampullary cancer in a patient with familial adenomatous polyposis - a rare case report and current status of management.

Bratislavske lekarske listy·2019
Same author

Adipose-tissue-derived therapeutic cells in their natural environment as an autologous cell therapy strategy: the microtissue-stromal vascular fraction.

European cells & materials·2019
Same author

The study of bacteria in biopsies from Slovak colorectal adenoma and carcinoma patients.

Neoplasma·2018
Same author

Fibrin-based delivery strategies for acute and chronic wound healing.

Advanced drug delivery reviews·2017
Same journal

Imunological aspects of kidney retransplantation.

Bratislavske lekarske listy·2024
Same journal

The effect of lengthening of the percutaneous implant in the surgical treatment of Th-L ankylosed spine fractures: 4 segment fixation versus 5 to 8 segment fixation.

Bratislavske lekarske listy·2024
Same journal

Prostate cancer in Slovakia: last decade overview.

Bratislavske lekarske listy·2024
Same journal

Cancer epidemiology in Slovakia.

Bratislavske lekarske listy·2024
Same journal

Peculiarities of nutritional support in patients with neoplasms of the hepatopancreatoduodenal zone as a component of intensive therapy in the postoperative period.

Bratislavske lekarske listy·2024
Same journal

A comparative review of coronary computed tomography angiography and myocardial perfusion imaging.

Bratislavske lekarske listy·2024
See all related articles

Barrett's esophagus significantly increases the risk of esophageal adenocarcinoma. Treatment for Barrett's esophagus without dysplasia mirrors gastroesophageal reflux disease management.

Area of Science:

  • Gastroenterology
  • Oncology

Background:

  • Barrett's esophagus is a precancerous condition associated with a substantially elevated risk of esophageal adenocarcinoma.
  • Patients diagnosed with Barrett's esophagus face a 30-40 fold increased risk of developing distal esophageal adenocarcinoma.

Purpose of the Study:

  • To highlight the increased risk of adenocarcinoma in patients with Barrett's esophagus.
  • To outline the treatment approach for Barrett's esophagus without dysplasia.

Main Methods:

  • Literature review and synthesis of existing data on Barrett's esophagus and esophageal adenocarcinoma.
  • Analysis of treatment guidelines for gastroesophageal reflux disease and Barrett's esophagus.

Main Results:

  • Barrett's esophagus confers a 30-40 times higher risk for adenocarcinoma of the distal esophagus.

Related Experiment Videos

  • The management of Barrett's esophagus in the absence of dysplasia is consistent with the treatment of gastroesophageal reflux disease.
  • Conclusions:

    • Early recognition and appropriate management of Barrett's esophagus are crucial for mitigating cancer risk.
    • Standard gastroesophageal reflux disease treatment protocols are applicable for Barrett's esophagus cases without dysplasia.